Dédicaces - Faculté de Médecine et de Pharmacie de Fès

70- Forastière AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al.
Concurrent chemotherapy and radiotherapy for organ preservation in advanced
laryngeal cancer.
N Engl J Med 2003;349:2091–8.
71- Vokes EE, Stenson K, Rosen FR, Kies MS, Rademacker AW, Witt ME, et al.
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracile
and hydroxyurea chemoradiotherapy: curative and organ-preservating therapy for
advanced head and neck cancer.
J Clin Oncol 2003;21:320–6.
72- Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, et al.
Docetaxel, cisplatine,5-fluorouracil (TPF)- based induction chemotherapy for head
and neck cancer and the case for sequential, combined modality treatment.
Oncologist 2003;8:35–44.
73- Urba S, Wolf G, Bradfort C.
Improved survival and decreased late salvage surgery using chemo-selection of
patients for organ preservation in advanced laryngeal cancer.
Proc Am Soc Clin Oncol 2003;22:497.
74- Laccourreye O, Veivers D, Hans S, Menard M, Brasnu D, Laccourreye H.
Chemotherapy alone with curative intent in patients with invasive squamous cell
carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical
responders.
Cancer 2001;92:1504–11.
75- Bonner JA, Giralt J, Harari PM, Cohen R, Jones C, Sur RK, et al.
Cetuximab prolongs survival in patients with locoregionally advanced squamous cell
carcinoma of head and neck: a phase III study of high dose radiation therapy with or
without cetuximab.
Proc Am Soc Clin Oncol 2004;23
76- Eckel HE.
Current status of endoscopic laser surgery in head and neck surgical oncology.
Otorhinolaryngol Nova 2002;12:21–32.
77- Davis RK, Kriskovitch MD, Galloway EB, Buntin CS, Jepsen MC.
Endoscopic supraglottic laryngectomy with postoperative irradiation.
Ann Otol Rhinol Laryngol 2004;113: 132–8.
147